Spire Wealth Management’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
6CM
Spire Wealth Management's ANAB Position: Q3 2026 in Review
Spire Wealth Management held its AnaptysBio (ANAB) position steady in Q3 2026 at 1,200 shares worth $60.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1090.
Spire Wealth Management first reported a position in ANAB in Q4 2021 and has held it in 7 quarters since. The position peaked at $81K in Q2 2026. 229 funds tracked by Wall St. Rank hold ANAB as of Q3 2026.
- Spire Wealth Management held 1,200 shares of AnaptysBio worth $60.3K as of Q3 2026.
- Spire Wealth Management left its AnaptysBio share count unchanged in Q3 2026.
- AnaptysBio made up ﹤0.01% of Spire Wealth Management's portfolio in Q3 2026, its #1090 holding.
- Spire Wealth Management first reported a position in AnaptysBio in Q4 2021 and has held it in 7 quarters since.
- Spire Wealth Management's AnaptysBio position peaked at $81K in Q2 2026.
- 229 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2026.
Based on Spire Wealth Management's 13F filing for Q3 2026, filed 30 Oct 2026.